Nafazatrom T33579
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Nafazatrom is a pyrazolinone derivative and lipoxygenase inhibitor that increases endogenous prostacyclin (PGI2) and has experimental anticancer activity. Nafazatrom is also an antithrombotic drug that increases prostacyclin levels and reduces the inciden
CAS nr:
59040-30-1
Purity:
98%
Molecular Weight:
268,31
SMILES:
O=C1N(CCOC2=CC=C3C=CC=CC3=C2)N=C(C)C1
Formula:
C16H16N2O2
Pathway:
Target:
